Vimarsana
Biggest News Aggregation in the World

Feng Ren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Feng Ren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Feng Ren Today - Breaking & Trending Today

Insilico's Potential Best-in-Class AI Drug for Sought-After Cancer Target - - Vimarsana News

Insilico's Potential Best-in-Class AI Drug for Sought-After Cancer Target -

InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of

Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors - Vimarsana News

Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors

Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM8001, a novel molecule targeting FGFR2/3 for the treatment of tissue-agnostic solid tumors bringing the total number of PCCs nominated in 2023 to six.

Clinical trials for first AI-generated drug being conducted on humans - Vimarsana News

Clinical trials for first AI-generated drug being conducted on humans

After having natural human-like conversations with humans, AI could potentially be treating them medically, as the first drug fully generated by artificial intelligence has now entered clinical...

First drug developed by generative AI administered to patients - Vimarsana News

First drug developed by generative AI administered to patients

Washington DC (UPI) Jul 2, 2023 - The first dose of a drug developed by artificial intelligence has been delivered to its first patient.

1st fully AI designed drug for lung disease enters human clinical trials - Vimarsana News

1st fully AI designed drug for lung disease enters human clinical trials

In a first, a drug discovered and designed using artificial intelligence (AI) for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic disease that causes scarring in the lungs, has entered human clinical trials.Hong Kong-based ...